Copyright
©The Author(s) 2019.
World J Gastroenterol. Jan 14, 2019; 25(2): 269-281
Published online Jan 14, 2019. doi: 10.3748/wjg.v25.i2.269
Published online Jan 14, 2019. doi: 10.3748/wjg.v25.i2.269
Feature | IBS-D patients | Controls | P-value |
N | 31 | 20 | NA |
Age (yr) | 33.0 (29.0-42.0) | 28.0 (26.0-36.0) | 0.056 |
Gender (male:female) | 22:09 | 13:07 | 0.654 |
Body mass index (kg/m2) | 24.2 ± 4.3 | 22.2 ± 2.6 | 0.095 |
Duration of disease (yr) | 5.0 (2.0-10.0) | NA | NA |
IBS-SSS | 274.2 ± 29.8 | NA | NA |
Severity of abdominal pain | 1.0 (1.0-2.0) | NA | NA |
VSI score | 54.0 (44.0-61.0)a | 21.0 (17.3-30.0) | < 0.001 |
HADS anxiety score | 6.0 (2.0-10.0)a | 3.0 (1.0-4.0) | 0.003 |
HADS depression score | 4.0 (1.0-8.0) | 2.5 (1.3-4.0) | 0.055 |
BDNF expression | |
Clinical characteristic | |
Severity of abdominal pain | 0.565 (0.001)a |
IBS-SSS | 0.393 (0.029)b |
Visceral sensitivity | |
First sensation threshold | -0.562 (0.001)a |
Defecating sensation threshold | -0.015 (0.938) |
Maximum tolerable threshold | -0.290 (0.113) |
RAIR threshold | -0.508 (0.004)a |
Mucosal nerve fiber density | -0.058 (0.756) |
- Citation: Zhang Y, Qin G, Liu DR, Wang Y, Yao SK. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2019; 25(2): 269-281
- URL: https://www.wjgnet.com/1007-9327/full/v25/i2/269.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i2.269